Literature DB >> 9642249

NF-Y organizes the gamma-globin CCAAT boxes region.

C Liberati1, A Ronchi, P Lievens, S Ottolenghi, R Mantovani.   

Abstract

The CCAAT-binding activator NF-Y is formed by three evolutionary conserved subunits, two of which contain putative histone-like domains. We investigated NF-Y binding to all CCAAT boxes of globin promoters in direct binding, competition, and supershift electrophoretic mobility shift assay; we found that the alpha, zeta, and proximal gamma CCAAT boxes of human and the prosimian Galago bind avidly, and distal gamma CCAAT boxes have intermediate affinity, whereas the epsilon and beta sequences bind NF-Y very poorly. We developed an efficient in vitro transcription system from erythroid K562 cells and established that both the distal and the proximal CCAAT boxes are important for optimal gamma-globin promoter activity. Surprisingly, NF-Y binding to a mutated distal CCAAT box (a C to T at position -114) is remarkably increased upon occupancy of the high affinity proximal element, located 27 base pairs away. Shortening the distance between the two CCAAT boxes progressively prevents simultaneous CCAAT binding, indicating that NF-Y interacts in a mutually exclusive way with CCAAT boxes closer than 24 base pairs apart. A combination of circular permutation and phasing analysis proved that (i) NF-Y-induced angles of the two gamma-globin CCAAT boxes have similar amplitudes; (ii) occupancy of the two CCAAT boxes leads to compensatory distortions; (iii) the two NF-Y bends are spatially oriented with combined twisting angles of about 100 degrees. Interestingly, such distortions are reminiscent of core histone-DNA interactions. We conclude that NF-Y binding imposes a high level of functionally important coordinate organization to the gamma-globin promoter.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9642249     DOI: 10.1074/jbc.273.27.16880

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  18 in total

1.  Role of NF-Y in in vivo regulation of the gamma-globin gene.

Authors:  Z Duan; G Stamatoyannopoulos; Q Li
Journal:  Mol Cell Biol       Date:  2001-05       Impact factor: 4.272

2.  Interference of transcriptional activation by the antineoplastic drug ecteinascidin-743.

Authors:  M Minuzzo; S Marchini; M Broggini; G Faircloth; M D'Incalci; R Mantovani
Journal:  Proc Natl Acad Sci U S A       Date:  2000-06-06       Impact factor: 11.205

3.  Characterization of the human ephrin-A4 promoter.

Authors:  Else Munthe; Hans-Christian Aasheim
Journal:  Biochem J       Date:  2002-09-01       Impact factor: 3.857

4.  Long-range function of an intergenic retrotransposon.

Authors:  Wenhu Pi; Xingguo Zhu; Min Wu; Yongchao Wang; Sadanand Fulzele; Ali Eroglu; Jianhua Ling; Dorothy Tuan
Journal:  Proc Natl Acad Sci U S A       Date:  2010-07-06       Impact factor: 11.205

5.  NF-Y behaves as a bifunctional transcription factor that can stimulate or repress the FGF-4 promoter in an enhancer-dependent manner.

Authors:  Cory T Bernadt; Tamara Nowling; Matthew S Wiebe; Angie Rizzino
Journal:  Gene Expr       Date:  2005

6.  Identification of a promoter for the human C1Q-tumor necrosis factor-related protein-5 gene associated with late-onset retinal degeneration.

Authors:  Venkata R M Chavali; Jeffrey R Sommer; Robert M Petters; Radha Ayyagari
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-06-16       Impact factor: 4.799

7.  Erythroid overexpression of C/EBPgamma in transgenic mice affects gamma-globin expression and fetal liver erythropoiesis.

Authors:  G Zafarana; R Rottier; F Grosveld; S Philipsen
Journal:  EMBO J       Date:  2000-11-01       Impact factor: 11.598

8.  A novel AP-1 site is critical for maximal induction of the follicle-stimulating hormone beta gene by gonadotropin-releasing hormone.

Authors:  Djurdjica Coss; Suzanne B R Jacobs; Cheryl E Bender; Pamela L Mellon
Journal:  J Biol Chem       Date:  2003-10-20       Impact factor: 5.157

9.  Recruitment of a repressosome complex at the growth hormone receptor promoter and its potential role in diabetic nephropathy.

Authors:  P M Gowri; J H Yu; A Shaufl; M A Sperling; R K Menon
Journal:  Mol Cell Biol       Date:  2003-02       Impact factor: 4.272

10.  Characterization of the human topoisomerase IIbeta (TOP2B) promoter activity: essential roles of the nuclear factor-Y (NF-Y)- and specificity protein-1 (Sp1)-binding sites.

Authors:  Chun-Nam Lok; Alexander J Lang; Shelagh E L Mirski; Susan P C Cole
Journal:  Biochem J       Date:  2002-12-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.